LADENBURG THALMANN FINANCIAL SERVICES INC. - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 65 filers reported holding NEOS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,0000.0%5200.0%0.00%
Q3 2019$1,0000.0%5200.0%0.00%
Q2 2019$1,0000.0%5200.0%0.00%
Q1 2019$1,0000.0%5200.0%0.00%
Q4 2018$1,000
-66.7%
5200.0%0.00%
Q3 2018$3,000
-25.0%
520
-7.5%
0.00%
Q2 2018$4,0000.0%5620.0%0.00%
Q1 2018$4,000
-20.0%
562
+8.1%
0.00%
Q4 2017$5,000
-50.0%
520
-66.2%
0.00%
Q3 2016$10,000
-28.6%
1,5370.0%0.00%
Q2 2016$14,000
-17.6%
1,5370.0%0.00%
Q1 2016$17,0001,5370.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,858,889$7,337,0005.11%
Proxima Capital Management, LLC 170,294$257,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 3,530,731$5,331,0000.44%
Nantahala Capital Management 4,610,000$6,961,0000.21%
Wealthstar Advisors, LLC 73,295$111,0000.07%
Alambic Investment Management, L.P. 51,733$78,0000.06%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$151,0000.05%
BCS Wealth Management 29,520$45,0000.03%
Allred Capital Management, LLC 24,995$37,742,0000.02%
ALGERT GLOBAL LLC 34,254$52,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders